The North America External Neurostimulation/Neuromodulation Devices Market report defines and segments the concerned market in North America with analysis and forecast of revenue. The external neurostimulation/neuromodulation devices market in North America was valued at $170.4 million 2012 and is estimated to grow at a CAGR of 9.7% from 2013 to 2018.

Browse through the TOC of the North American External Neurostimulation/Neuromodulation devices market, to get an idea of the in-depth analysis provided. This also provides a glimpse of the segmentation of the external neurostimulation/neuromodulation devices market in the same region, and is supported by various tables and figures.

http://www.micromarketmonitor.com/market/north-america-external-neurostimulation-2396937734.html

The main drivers for the North American external neurostimulation/neuromodulation devices market are the rising population of aged people and the increase in age-related diseases such as Alzheimer’s, epilepsy, spinal cord injury, Parkinson’s disease, urine and fecal incontinence, and depression. The large pool of patients that suffer from depression, stroke, anxiety disorders, lower back pain, urinary incontinence, and tremor provides the external neurostimulation/neuromodulation devices market with opportunities to grow in the coming years.

According to the U.S. Alzheimer’s Associations, approximately 5 million Americans suffered from Alzheimer’s in 2012. In addition, about 80% of the people aged 65 and above suffered from at least one chronic condition, according to the Center for Disease Control and Prevention. Also, in the next five years, primarily due to technical advances and patient-friendly techniques, the demand for minimally invasive and non-invasive procedures is expected to grow, leading to growth of the external neurostimulation/neuromodulation market in the North American region.

The key players in this market include Medtronic (U.S.), St.Jude Medical (U.S.), Boston Scientific Corporation(U.S.), and Cyberonics(U.S.), among others; while Neuronetics(U.S.), Neurosigma (U.S.), MicroTransponder(U.S.), Neuropace(U.S.), Functional Neuromodulation Ltd. (U.S.), and Zynex, Inc(U.S.), among others, represent the emerging players of the market.

This market is segmented and forecast on the basis of type and the modality of external neurostimulation/neuromodulation devices in the North American region. The external neurostimulation/neuromodulation devices market segments itself into Transcutaneous Electrical Nerve Stimulation (TENS) and Transcranial Magnetic Stimulation (TMS) devices. On the basis of surgery procedures, the market is segmented into direct nerve repair, nerve grafting, and stem cell therapy. The market is further segmented and forecast on the basis of the major countries in the region, such as the U.S., Canada, and Mexico.

This report also includes market share and value chain analyses, along with market metrics such as drivers, restraints, and upcoming opportunities in the market. In addition, it presents a competitive landscape and company profiles of the key players in the market.

About MicroMarket Monitor:
MicroMarket Monitor identifies and attends to various unmet needs of different industrial verticals, which include value chain impact analysis. The company publishes about 12000 Market Research Reports on various Micro Markets across the world. The graphical nature and multidimensional analysis of these reports provide advanced Business Intelligence Tools to the clients in that particular target market.

Contact:
Mr. Chandrasekhar K.
5601 Bridge Street
Suite 300
Fort Worth, TX 76112
Tel: +1-888-502-0539
Email: [email protected]